Faster generic approval process by U.S. FDA will benefit Indian drugmakers

05/11/2014 | Business Standard (India)

The U.S. FDA's plans to expedite generic-drug approvals should result in more Indian drugs being introduced in the United States, according to an industry official. The application review period is set to change from three years to 11 months. India is the largest foreign supplier of generic medicines to the U.S., with major drugmakers filing 15 to 20 generic-drug applications each year.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Actuary
NTA Life
Addison, TX
Vice President - Government Products
Health Alliance Plan
Detroit, MI